Multicausality in fatty liver disease: Is there a rationale to distinguish between alcoholic and non-alcoholic origin?
Open Access
- 1 January 2012
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 18 (27), 3492-501
- https://doi.org/10.3748/wjg.v18.i27.3492
Abstract
Apart from alcohol, there are other factors that may induce complications, which resemble alcohol-related liver disorders. In particular, obesity has been brought into focus as a risk factor for fatty liver disease. The term "non-alcoholic" fatty liver disease is commonly used to distinguish between obesity-related and alcohol-related hepatic steatosis. This review uses the epidemiological perspective to critically assess whether it is necessary and useful to differentiate between alcoholic and "non-alcoholic" fatty liver disease. The MEDLINE database was searched using the PubMed search engine, and a review of reference lists from original research and review articles was conducted. The concept to distinguish between alcoholic and "non-alcoholic" fatty liver disease is mainly based on specific pathomechanisms. This concept has, however, several limitations including the common overlap between alcohol misuse and obesity-related metabolic disorders and the non-consideration of additional causal factors. Both entities share similar histopathological patterns. Studies demonstrating differences in clinical presentation and outcome are often biased by selection. Risk factor reduction is the main principle of prevention and treatment of both disease forms. In conclusion, alcoholic and "non-alcoholic" fatty liver diseases are one and the same disease caused by different risk factors. A shift from artificial categories to a more general approach to fatty liver disease as a multicausal disorder may optimize preventive strategies and help clinicians more effectively treat patients at the individual level.Keywords
This publication has 85 references indexed in Scilit:
- Non-alcoholic and alcoholic Fatty Liver Disease - two Diseases of Affluence associated with the Metabolic Syndrome and Type 2 Diabetes: the FIN-D2D SurveyBMC Public Health, 2010
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic SteatohepatitisNew England Journal of Medicine, 2010
- Role of Alcohol Metabolism in Non-Alcoholic SteatohepatitisPLOS ONE, 2010
- Cohort Profile: The Study of Health in PomeraniaInternational Journal of Epidemiology, 2010
- Similarities and Differences in the Pathogenesis of Alcoholic and Nonalcoholic SteatohepatitisSeminars in Liver Disease, 2009
- Extended recruitment efforts minimize attrition but not necessarily biasJournal of Clinical Epidemiology, 2008
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver diseaseNature Genetics, 2008
- Global burden of obesity in 2005 and projections to 2030International Journal of Obesity, 2008
- Menopausal status and hepatic steatosis in a general female populationGut, 2007
- Cryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying DiseaseHepatology, 1999